Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

166 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
18F-FDG PET Improves Baseline Clinical Predictors of Response in Diffuse Large B-Cell Lymphoma: The HOVON-84 Study.
Burggraaff CN, Eertink JJ, Lugtenburg PJ, Hoekstra OS, Arens AIJ, de Keizer B, Heymans MW, van der Holt B, Wiegers SE, Pieplenbosch S, Boellaard R, de Vet HCW, Zijlstra JM; HOVON Imaging Working Group and the HOVON Lymphoma Working Group. Burggraaff CN, et al. Among authors: de vet hcw, de keizer b. J Nucl Med. 2022 Jul;63(7):1001-1007. doi: 10.2967/jnumed.121.262205. Epub 2021 Oct 21. J Nucl Med. 2022. PMID: 34675112 Free PMC article. Clinical Trial.
Assessment of the risk of malignancy in Bethesda III thyroid nodules: a comprehensive review.
Rao KN, Randolph GW, Lopez F, Zafereo M, Coca-Pelaz A, Piazza C, Dange P, Rodrigo JP, Stenman G, de Keizer B, Nixon I, Sinha S, Leboulleux S, Mäkitie AA, Agaimy A, Thompson L, Ferlito A; This paper was written by members and invitees of the International Head and Neck Scientific Group. Rao KN, et al. Among authors: de keizer b. Endocrine. 2024 Aug;85(2):473-492. doi: 10.1007/s12020-024-03737-z. Epub 2024 Feb 28. Endocrine. 2024. PMID: 38416380 Review.
Systematic review and meta-analysis on the diagnostic performance of FDG-PET/CT in detecting bone marrow involvement in newly diagnosed Hodgkin lymphoma: is bone marrow biopsy still necessary?
Adams HJ, Kwee TC, de Keizer B, Fijnheer R, de Klerk JM, Littooij AS, Nievelstein RA. Adams HJ, et al. Among authors: de klerk jm, de keizer b. Ann Oncol. 2014 May;25(5):921-7. doi: 10.1093/annonc/mdt533. Epub 2013 Dec 18. Ann Oncol. 2014. PMID: 24351400 Free article. Review.
Relationship between pretreatment FDG-PET and diffusion-weighted MRI biomarkers in diffuse large B-cell lymphoma.
de Jong A, Kwee TC, de Klerk JM, Adam JA, de Keizer B, Fijnheer R, Kersten MJ, Ludwig I, Jauw YW, Zijlstra JM, Pieters-Van den Bos IC, Stoker J, Hoekstra OS, Nievelstein RA. de Jong A, et al. Among authors: de klerk jm, de keizer b. Am J Nucl Med Mol Imaging. 2014 Apr 25;4(3):231-8. eCollection 2014. Am J Nucl Med Mol Imaging. 2014. PMID: 24795837 Free PMC article.
Quantitative Comparison of 124I PET/CT and 131I SPECT/CT Detectability.
Beijst C, Kist JW, Elschot M, Viergever MA, Hoekstra OS, de Keizer B, de Jong HW. Beijst C, et al. Among authors: de jong hw, de keizer b. J Nucl Med. 2016 Jan;57(1):103-8. doi: 10.2967/jnumed.115.162750. Epub 2015 Oct 22. J Nucl Med. 2016. PMID: 26493205 Free article.
166 results